By Shalini Bhardwaj

Pune (Maharashtra) [India], June 18 (ANI): The NAKSHATRA state-of-the-art initiative aims to revolutionise how genomic and bioinformatics data are processed, addressing limitations faced during the COVID-19 pandemic.

Also Read | Gaya Unrest: Tension Grips Bihar District as Man Dies After Being Lynched by Rival Group; Security Beefed Up in Village, Investigation Underway (See Pics).

Speaking to ANI, ICMR-NIV Pune Director Dr Naveen Kumar, explaining about NAKSHATRA, said, "A high-performance computing system has been launched. This is the first kind of facility for the sequence analysis or genomic surveillance of pathogens under the ICMR."

He further said, "So nowadays, many new COVID variants, viruses, or pathogens are being reported. Our resources were insufficient because analysing the millions of sequences in the public domain takes a lot of time. We were doing extensive sequence analysis using multiple strains, which used to take weeks.Now we can do the same work in 24-48 hours. It has increased the capability of our country for genomic surveillance, which will help us in pandemic preparedness."

Also Read | Bengaluru Water Cut: BWSSB Announces 24-Hour Water Supply Disruption on June 19 Amid Urgent Cauvery Pipeline Work; Check Timings and List of Affected Areas.

Developed under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PMABHIM), the HPC facility forms the cornerstone of a new project titled "High Performance Computing Next Generation Sequencing (NGS) Hub". The initiative aims to revolutionize how genomic and bioinformatics data are processed, addressing limitations faced during the COVID-19 pandemic due to conventional computing infrastructure.

The commissioning of the NAKSHATRA HPC facility is not just a technological upgrade--it is a national investment in speed, precision, and preparedness. By enabling faster analysis of complex genomic data, the facility positions India to detect new disease threats sooner, respond to outbreaks more efficiently, and accelerate AI-driven vaccine and drug development. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)